Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer

19 Apr 2025

Abstract excerpt

Plasma DNA methylation SEPTIN9, Syndecan 2 (SDC2), and Branched Chain Amino Acid Transaminase 1 (BCAT1) tests have served as valuable diagnostic, prognostic, and predictive markers for colorectal cancer (CRC). In this study, we analyzed data including 104 eligible CRC patients, 138 colorectal benign diseases, and 106 healthy subjects in our hospital from January 2019 to May 2023. This study was approved by the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Screening and Detection
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40253416
DOI: 10.1038/s41598-025-95712-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancerPMID 40253416Read ↗

The Screening Value of Septin9, SDC2, and BCAT1 Triple Gene Methylation Detection Combined with Colonoscopy for Early Colorectal CancerSemantic proximity Read ↗

DNA methylation analysis of SCD2, SEPT9 and VIM genes for the early detection of colorectal cancer in fecal DNASemantic proximity Read ↗

DNA methylation analysis of the SDC2, SEPT9 and VIM genes in fecal DNA for colorectal cancer diagnosisSemantic proximity Read ↗

Roles of Methylated DNA Biomarkers in Patients with Colorectal CancerSemantic proximity Read ↗

DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancerSemantic proximity Read ↗

Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancerSemantic proximity Read ↗

Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detectionSemantic proximity Read ↗

Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: a multicentre cohort studySemantic proximity Read ↗

Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancerSemantic proximity Read ↗

Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early DetectionSemantic proximity Read ↗

DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicineSemantic proximity Read ↗

Identification of methylation biomarkers in colorectal carcinoma and their detection in circulating tumour cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.